TAXS, RODM, & CBLI: Rodman & Renshaw Announces Analyst Discussion with Cleveland BioLabs, Inc.

Aug. 3, 2010 - PRLog -- TAXS, TaxMasters (OTC BB:TAXS)

TaxMasters, Inc. the IRS tax relief company, is the first publicly traded tax representation firm in the United States.  Started by Patrick R. Cox in 2001, TaxMasters offers services and counsel to taxpayers across the country facing seemingly insurmountable tax problems, and relief from substantial federal tax debt.

Employing over 300 people, TaxMasters leverages the expertise of ex-IRS agents, enrolled agents, attorneys, CPAs, and seasoned tax consultants ready to counsel and assist every day people with their specific tax problems today.

TaxMasters filed a Current Report on Form 8-K on Wednesday, July 7, 2010 to announce that Patrick Cox, its founder, CEO and majority shareholder, voluntarily entered into a Financial Reorganization Agreement in which Mr. Cox deposited 200 million shares of his TaxMasters common stock with TaxMasters’ transfer agent, Olde Monmouth Stock Transfer Co., Inc. These shares will be held in escrow by Olde Monmouth for a five year period ending June 30, 2015. During that time, Mr. Cox has waived his right to vote the escrowed shares and he has also waived his right to receive any dividends or other distributions by TaxMasters with respect to the escrowed shares. As a result of Mr. Cox’s voluntary escrow of shares, there are now 139,676,105 shares of common stock that can be voted or can receive dividends or other distributions. The 139,676,105 shares will also be the number of shares used to calculate earnings per share for TaxMasters financial statements.

______________________________



RODM, Rodman & Renshaw Capital Group, Inc.

Rodman & Renshaw is a full-service investment bank dedicated to providing corporate finance, strategic advisory and related services to public and private companies across multiple sectors and regions. Rodman also provides research and sales and trading services to institutional investors. Rodman is the leader in the PIPE (private investment in public equity) and RD (registered direct offering) transaction markets. According to Sagient Research Systems, Rodman has been ranked the #1 Placement Agent in terms of the aggregate number of PIPE and RD financing transactions completed every year since 2005.

Rodman & Renshaw, a leading full service investment bank for growth companies today announced that on August 10, 2010, Rodman will host an analyst discussion in its media center with Michael Fonstein, Ph.D., President and Chief Executive Officer, Andrei Gudkov, Ph.D., D. Sci., Chief Scientific Officer, of Cleveland BioLabs, Inc. and Craig Vanderwagen, MD, a Partner with Martin, Blanck & Associates, a federal health services consulting firm based in Falls Church, Virginia.

Dr. Vanderwagen offers unique and groundbreaking experience in biodefense, domestic disaster preparedness and response, international humanitarian and disaster response, federal health delivery systems, innovative organization development and evaluation, and cross-cultural health care.

______________________________



Cleveland BioLabs, Inc. (NasdaqCM: CBLI)

Cleveland Biolabs, Inc. engages in the discovery, development, and commercialization of products for cancer treatment and protection of normal tissues from radiation and other acute stresses. The company’s products include Protectan CBLB502, a radioprotectant molecule with multiple medical and defense applications for reducing injury from acute stresses, such as radiation and chemotherapy by mobilizing various natural cell protecting mechanisms, including inhibition of apoptosis, reduction of oxidative damage, and induction of factors that induce protection and regeneration of stem cells in bone marrow and intestine.

Rodman & Renshaw, a leading full service investment bank for growth companies today announced that on August 10, 2010, Rodman will host an analyst discussion in its media center with Michael Fonstein, Ph.D., President and Chief Executive Officer, Andrei Gudkov, Ph.D., D. Sci., Chief Scientific Officer, of Cleveland BioLabs, Inc. and Craig Vanderwagen, MD, a Partner with Martin, Blanck & Associates, a federal health services consulting firm based in Falls Church, Virginia.

The event will be hosted by Simos Simeonidis, Ph.D., Managing Director and Senior Biotechnology Analyst, of Rodman & Renshaw, LLC. The topics to be covered will include a discussion of the company's pipeline compounds, and will include the latest update on CBLI's lead program, CBLB502, currently in development for the treatment of Acute Radiation Syndrome.



*******************************************
Sign-Up For Free Stock Alerts At http://crwepicks.com/signup
*******************************************





THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment.The CRWEPicks.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer (http://crwepicks.com/disclaimer ) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEpicks.com report and Crown Equity Holdings, Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (read more ) Rule 17B requires disclosure of payment for investor relations.Crown Equity Holdings, Inc. (CRWE.OB) has previously received twenty four thousand dollars from Tax Masters Inc.(TAXS.OB) for 30 days of advertisement services. Crown Equity Holdings, Inc. (CRWE.OB) has received four thousand dollars from a third party (Marshall Curtis) for 30 days of advertisement services for Tax Masters Inc.(TAXS.OB).





*******************************************

# # #

Crown Equity Holdings Inc. assists and consults with domestic and foreign companies interested in becoming publicly traded in the U.S. The company designs and manufactures multi-monitor computer systems for financial traders and audio/video professionals.